Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioVaxys Technology Corp. BVAXF


Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.


CSE:BIOV - Post by User

Comment by javaman12on Oct 30, 2024 9:04pm
44 Views
Post# 36289848

RE:RE:RE:On the other hand the CEO sees a market cap in the billions

RE:RE:RE:On the other hand the CEO sees a market cap in the billions As a followup to my previous commentary and speculation, regarding BioVaxys CEO James Passin's suggestion that IMV may have gone bankrupt because they may have refused to partner with a bigger pharmaceutical company.

What if it was big pharma that refused to do the partnering with them because of big pharma's selfish need to sell more vaccination and cancer products into the market! They made a lot of big money with the need for multple shots of their covid-19 vaccines over the years! The same could be said for the need for continuous influenza shots! These could be just a few examples about what may really be going on to recreate an excessive vaccination need! 

Could the real purpose be to make a lot more profit by concealing most of the truth. That would make it a conspiracy if all of the parties are later found to be cooperating illegally and found guilty as charged! 

What would have been the consequences for them if they could have got a knock out punch against any one virus with a one shot killer vaccine punch! Perhaps, they might have received a lot fewer commercial revenue streams? 

Would they have lost a lot of money in their development costs? Or would their profits been a lot less? 

Today the way to make a lot more money is to create a license for the use a product to be paid on a yearly basis! Isn't that something like Pharmaceutical companies are doing with yearly vaccines?

Maybe Microsoft got this kind of idea first from the Pharmaceutical companies. That's how most of the money is made these days by the biggest and most successful software companies!

Is this a part of the reason that IMV may have gone bankrupt because they had no other choice than to go it alone?

Does a weaker delivery system allow viruses like covid, flu or any other to linger and mutate year after year because they weren't completely destroyed?  Could even the common cold virus be completely eliminated if the proper vaccine delivery system delivered the goods?

Remember what the doctor says about completing your total dosage of anti-biotic when your body is confronted with a difficult to treat bacterial infection? Take the complete dose to kill all of those microscopic parasitic bugs! Or they will mutate and infect many other people and make the anti-botic in use, less effective or even useless!

If the warning to finish the dosage isn't heeded by the majority of users, the greater need for a new and more expensive drug to combat such a disease is newly created!

The continiuing mutation of pathogens makes a growing large pharmaceutical company even busier! Their share price rises in lockstep to an increasing trend of growing illness and drug inefficacy especially as the world's population travels easily from any place to place!

Do you realize the significance of this kind of information if any of this could be proved as a fact?

                                                 Just something to ponder!

                                                      And wonder about!

                                                       All the best! Java
<< Previous
Bullboard Posts
Next >>